$INBS Cashflow Statement | Understand Stock

$INBS

$1.64 +$0.05 (3.14%) Close

$INBS Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2026 12 months to Jun 30, 2026	FY2025 12 months to Jun 30, 2025	FY2024 12 months to Jun 30, 2024	FY2023 12 months to Jun 30, 2023	FY2022 12 months to Jun 30, 2022
Cash flows from operating activities
Net loss
Adjustments to reconcile net loss to cash used in operating activities:
Non-cash (loss) gain on foreign currency translation, net
Non cash refund of R&D expenditure claims
Amortization of right-of-use assets
Depreciation and amortization
Impairment of long-lived assets
Non-cash loss on foreign currency translation, net
Provision for credit losses
Inventory write-downs
Goodwill impairment
Stock-based compensation
Non-cash research and development charge
Non-cash refund of R&D expenditure claims
Fair value gain on revaluation of convertible notes
Non-cash adjustment on R&D expenditure claims
Fair value gain on revaluation of holdback Series C Preferred Stock
Non-cash other operating activities
Changes in operating assets and liabilities:
Accounts receivable
Inventories
Grant receivable / deferred grant income
Research and development tax incentive receivable
Other current assets
Accounts and other payables
Accounts payable - related party
Accounts payable and accrued expenses
Long-term employee benefit liabilities
Operating lease liabilities

Net cash used in operating activities
Cash flows from investing activities
Issuance of note receivable
Amount invested on construction in progress
Cash payment for business acquisition
Cash acquired from business acquisition
Proceeds from sale of assets held for sale
Purchase of property and equipment
Amount invested on capital work in progress
Net cash used in investing activities

Cash flows from financing activities
Proceeds from issuance of common stock, net of issuance costs
Proceeds from exercise of warrants, net of issuance costs
Proceeds from private placement, net of issuance costs
Proceeds from issuance of preferred stock
Payment of equity issuance costs - others
Payment of equity issuance costs relating to acquisition of IFP
Payment of tax withholding for employee stock awards
Proceeds from issuance of common stock for warrants exercised, net of issuance costs
Net cash provided by financing activities

Effect of foreign exchange rates on cash and cash equivalents
Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents, beginning of period
Cash and cash equivalents, end of the period
Non-cash investing and financing activities
Conversion of preferred shares into common shares
Shares issued for business acquisition
Deferred consideration payable for business acquisition
Deferred consideration payable for business combination
Recording of right-of-use asset and lease liability
Conversion of convertible notes payable into preferred stock
Equity issuance costs in accounts payable and accrued expenses
Conversion of preferred shares into common shares
Conversion of holdback Series C Preferred Stock into common stock
Operating lease assets obtained in exchange for operating lease liabilities
Issuance of common stock upon cashless exercise of Series F warrants

Comments